Anti-GLP-1R antibody [EPR21819],Abcam,AB218532

Product Specifications Anti-GLP-1R antibody [EPR21819] (ab218532) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-Fr, IHC-P, WB in mouse, rat samples. Anti-GLP-1R antibody [EPR21819] (ab218532) specifically detects GLP-1R (UniProt ID: O35659; Molecular weight: 51kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-GLP-1R antibody [EPR21819] (ab218532) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-GLP-1R antibody [EPR21819] (ab218532) has been cited over 20 times in peer reviewed journals and is trusted by the scientific community. Anti-GLP-1R antibody [EPR21819] (ab218532) has 6 independent reviews from customers. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .